What Is an Oocyte Cell and What Is Its Function?

An oocyte is the female reproductive cell, commonly called an egg cell, and its central function is to carry half the genetic material needed to create a new organism. But calling it just a carrier of DNA drastically undersells what oocytes actually do. These cells are among the largest in the human body, and for good reason: they stockpile proteins, messenger RNA, energy-producing organelles, and signaling molecules that will power the earliest stages of embryonic development long before the embryo’s own genes switch on. Understanding how oocytes form, mature, communicate with their surrounding cells, and eventually get fertilized reveals why they are so often the limiting factor in human fertility.

How an Oocyte Forms and Why It Waits

Oocytes begin their life during fetal development. In a human female fetus, precursor cells called oogonia multiply and then enter the early stages of cell division, specifically the first phase of meiosis. But they do not finish dividing. Instead, each oocyte halts at a stage called prophase I and stays there, sometimes for decades, until a hormonal signal tells it to resume. A newborn girl has her full supply of these paused oocytes already sitting in her ovaries, wrapped inside tiny structures called primordial follicles.

This paused state is actively maintained. Two chemical messengers inside the cell, cyclic AMP and cyclic GMP, work together to keep the oocyte locked in arrest.

1PubMed Central. The art of oocyte meiotic arrest regulation The surrounding support cells, called granulosa cells, continuously feed these signals to the oocyte through tiny channels. As long as that chemical conversation keeps flowing, the oocyte stays dormant. This is not a passive sleep; it is an energetically maintained holding pattern that protects the cell’s chromosomes from damage over the years.

The pool of dormant primordial follicles is sometimes called the ovarian reserve. It shrinks steadily throughout life, and a hormone called anti-Müllerian hormone (AMH) plays a key role in preventing too many dormant follicles from waking up at once. AMH helps keep primordial follicles in their resting state, slowing the rate at which the reserve is depleted.2PubMed. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice When AMH signaling is disrupted, follicles activate prematurely and the reserve can burn through faster than it should.3PubMed Central. The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy

The Hormonal Trigger That Wakes It Up

Each menstrual cycle, a small group of follicles begins to grow, and typically one becomes dominant. The oocyte inside that follicle is still paused in prophase I, still receiving “stay quiet” signals from its granulosa cells. What finally breaks the arrest is a surge of luteinizing hormone (LH) from the pituitary gland, triggered by rising estrogen levels from the maturing follicle.

The LH surge sets off a cascade inside the follicle. It shuts down the system that was keeping cyclic AMP high inside the oocyte, both by closing the gap junctions between the granulosa cells and the oocyte and by turning off a signaling molecule called NPPC that was sustaining the chemical block.4Frontiers in Cell and Developmental Biology. Mechanisms of Oocyte Maturation and Related Epigenetic Regulation At the same time, LH ramps up epidermal growth factor-like signals in the granulosa cells, amplifying the message. With cyclic AMP levels falling, a protein complex called the maturation-promoting factor activates inside the oocyte, and the cell finally resumes dividing.5PubMed Central. Luteinizing Hormone Action in Human Oocyte Maturation and Quality: Signaling Pathways, Regulation, and Clinical Impact

The exact way LH causes cyclic AMP to drop inside the oocyte has been surprisingly tricky to pin down. Researchers have ruled out some of the most obvious candidates. In mouse experiments, blocking a major family of signaling proteins (Gi-type G proteins) or preventing calcium from rising inside the oocyte did not stop the LH response.6PubMed Central. Meiotic resumption in response to luteinizing hormone is independent of a Gi family G protein or calcium in the mouse oocyte The picture that has emerged is that LH acts primarily by cutting off the supply of cyclic nucleotides flowing into the oocyte from its neighbors, rather than by directly flipping a switch inside the oocyte itself.

An Unequal Division on Purpose

When the oocyte finally resumes meiosis, it does not split into two equal halves the way most dividing cells do. Instead, it performs a dramatically lopsided division: one large cell retains almost all the cytoplasm, and a tiny cell called a polar body gets pinched off with very little more than a set of chromosomes. This asymmetry is the whole point. The oocyte needs to shed half its chromosomes to be ready for fertilization while keeping its massive stockpile of proteins, RNA, and organelles intact for the future embryo.7PubMed. DDX5 regulates asymmetric division of mouse oocytes by modulating the stability of microfilament-associated protein radixin

Pulling off this asymmetric division requires the cell’s internal skeleton to move the spindle, the structure that separates chromosomes, to a position near the cell’s edge rather than in its center. A signaling protein called Cdc42 accumulates in a patch of the cell surface directly above the chromosomes and drives the formation of an actin-rich bulge that becomes the polar body.8PubMed Central. Polarized Cdc42 activation promotes polar body protrusion and asymmetric division in mouse oocytes After this first polar body is expelled, the oocyte pauses again, this time at metaphase II. It will only complete its second meiotic division if a sperm fertilizes it.

How the Oocyte Talks to Its Neighbors

An oocyte does not grow in isolation. It sits at the center of its follicle, surrounded by layers of granulosa cells that supply it with nutrients, signaling molecules, and small metabolites it cannot efficiently produce on its own. But there is a physical barrier between them: a thick coat of sugary proteins called the zona pellucida that the oocyte itself secretes as it grows.

To maintain contact despite this barrier, the granulosa cells extend thin finger-like projections called transzonal projections (TZPs) that thread through the zona pellucida and make direct contact with the oocyte’s surface. Where TZPs touch the oocyte, gap junctions form, creating channels small enough to pass molecules like cyclic AMP, amino acids, and other metabolites directly into the egg.9PubMed Central. History, origin, and function of transzonal projections: the bridges of communication between the oocyte and its environment This two-way communication is essential. Without it, the oocyte cannot grow to full size or acquire the molecular machinery it needs to support an embryo after fertilization.

The zona pellucida itself is more than a passive shell. It undergoes active remodeling during maturation, with changes in its pore size, sugar composition, and structural uniformity that affect how sturdy and selectively permeable it is. After ovulation, the zona pellucida plays a direct role in fertilization by binding sperm, and after a sperm enters, it hardens to help block additional sperm from getting in.10PubMed Central. Dynamic Remodeling of the Zona Pellucida: Implications for Oocyte Competence and Assisted Reproduction

A Warehouse for the Early Embryo

One of the oocyte’s most underappreciated functions is as a storage unit. During its long growth phase, the oocyte accumulates enormous quantities of messenger RNA molecules, proteins, and organelles that will not be needed by the oocyte itself but will be critical for the embryo after fertilization. The embryo’s own genome does not become active right away. For the first several cell divisions, development is driven almost entirely by these maternal supplies.

The stored messenger RNAs are not all translated at once. They are held in a dormant state, packaged into specialized storage structures within the cell, and recruited for translation at specific times when particular proteins are needed.11Cambridge University Press. Transcription, accumulation, storage, recruitment, and degradation of maternal mRNA in mammalian oocytes This timed release is controlled by RNA-binding proteins. When one of these proteins, LSM14B, is missing in mice, the oocyte’s mRNA stockpile degrades prematurely and fertility collapses.12PubMed Central. LSM14B controls oocyte mRNA storage and stability to ensure female fertility

Mitochondria are another critical part of the oocyte’s cargo. These energy-producing organelles are needed in unusually large numbers because the early embryo is metabolically demanding and does not yet have the ability to ramp up its own mitochondrial production. Mitochondrial dysfunction in the oocyte has been linked to poor egg quality and problems with embryonic development.13PubMed Central. Oocyte mitochondrial function and reproduction

Eventually, the embryo must switch from running on maternal supplies to activating its own genome, a transition called the maternal-to-zygotic transition. During this process, the cytoplasm and nuclear chromatin inherited from the oocyte are reprogrammed to create a permissive environment for the embryo’s genes to turn on, establishing the foundation for all future development.14PubMed Central. The maternal-to-zygotic transition: reprogramming of the cytoplasm and nucleus

Why Oocyte Quality Drops with Age

The age-related decline in fertility is, in large part, an oocyte quality problem. Because oocytes are formed before birth and sit in arrested meiosis for years or decades, their internal machinery degrades over time. The most consequential damage involves a protein complex called cohesin, which acts like a molecular clamp holding paired chromosomes together. Over the years, cohesin gradually breaks down and is not replaced, making it more likely that chromosomes will separate incorrectly when the oocyte finally resumes division.15PubMed. Causes and consequences of chromosomal cohesin loss: Novel insights for mechanisms of aging-related oocyte aneuploidy

Incorrect chromosome separation, called aneuploidy, is the leading cause of miscarriage and chromosomal conditions like Down syndrome. The rate of aneuploidy rises sharply in a woman’s late 30s and early 40s, closely tracking the cumulative loss of cohesin. Interestingly, research in mice has shown that calorie restriction promotes the expression of genes involved in chromosome segregation and helps maintain cohesin integrity, potentially slowing this aspect of oocyte aging.16PubMed Central. Single-oocyte transcriptome analysis reveals aging-associated effects influenced by life stage and calorie restriction Whether this translates to humans remains an open question, but it highlights that oocyte aging is not purely a matter of the calendar; cellular maintenance mechanisms play a role too.

Environmental Chemicals and Oocyte Damage

Oocytes are sensitive to environmental exposures, and a growing body of research points to endocrine-disrupting chemicals (EDCs) as a threat to egg quality. Bisphenol A (BPA), found in certain plastics and can linings, is among the most studied. A scoping review found that the vast majority of both laboratory and animal studies documented harmful effects of BPA on oocytes, including abnormal spindle formation, disrupted chromosome alignment, and increased meiotic arrest. The review noted that adverse effects appeared even at exposure levels below those currently considered safe for humans.17PubMed Central. Impact of Bisphenol A and its alternatives on oocyte health: a scoping review

BPA substitutes marketed as safer alternatives, including BPF and BPS, showed similarly high rates of adverse effects in laboratory studies. EDCs are not limited to bisphenols. Phthalates, commonly found in fragrances and soft plastics, have been identified as a major contributor to negative outcomes in fertility treatment settings. In a study of women undergoing assisted reproduction, mixtures of EDCs detected in the fluid surrounding developing oocytes were associated with fewer mature eggs retrieved, fewer normally fertilized oocytes, and fewer high-quality embryos.18PubMed. The effect of endocrine-disrupting chemicals in follicular fluid: The insights from oocyte to fertilization One of the mechanisms through which EDCs damage oocytes is oxidative stress, where an excess of reactive oxygen molecules overwhelms the cell’s antioxidant defenses and damages DNA.19Frontiers in Public Health. Endocrine disruptor chemicals exposure and female fertility declining: from pathophysiology to epigenetic risks

When Oocytes Fail to Mature

For some women, the problem is not gradual age-related decline but a complete failure of oocytes to mature. In fertility treatment cycles, this shows up as a batch of eggs that all stop developing at the immature stage. Genetic mutations are increasingly recognized as a cause. One of the first genes identified was TUBB8, which encodes a protein that forms the structural backbone of the meiotic spindle. Mutations in TUBB8 account for roughly 30% of cases where oocytes arrest at the earliest stage, called germinal vesicle arrest.20American Journal of Human Genetics. Biallelic Mutations in PATL2 Cause Female Infertility Characterized by Oocyte Maturation Arrest

That same research team went on to identify another gene, PATL2, whose mutations cause a similar maturation arrest. Mutations in PATL2 reduce the amount of its protein product in the oocyte, disrupting processes needed for meiotic progression. Since then, additional genes like ZFP36L2 have been linked to oocyte maturation arrest, and researchers expect more to be found.21PubMed Central. Genetic factors of oocyte maturation arrest: an important cause for recurrent IVF/ICSI failures Beyond single-gene defects, aneuploidy, mitochondrial genome problems, and broader epigenetic disruptions can all cause oocytes to fail at various stages of maturation or early embryo development.22PubMed Central. Genetics of Oocyte Maturation Defects and Early Embryo Development Arrest

Freezing Oocytes Without Breaking Them

Egg freezing has become one of the most significant clinical applications of oocyte biology. The challenge is that oocytes are large, water-rich cells with a delicate internal structure, and the meiotic spindle holding chromosomes in place is especially vulnerable to cold. Early slow-freezing methods caused ice crystals to form inside the cell, damaging the spindle and displacing chromosomes. Vitrification, a rapid-cooling technique that turns the cell’s water into a glass-like solid without forming ice, has largely replaced slow freezing because it preserves the spindle and chromosome alignment much more reliably. In mouse studies, vitrified oocytes maintained normal spindles and chromosome alignment at a rate of about 87%, compared to 70% for slow-frozen oocytes.23PubMed. Effect of choline-supplemented sodium-depleted slow freezing versus vitrification on mouse oocyte meiotic spindles and chromosome abnormalities

Even with vitrification, the spindle does not survive the process unchanged. Research in mice has shown that spindle microtubules disassemble during cooling and then reassemble after warming, going through a phase of excessive growth before settling back into a normal shape. The organizing centers at each end of the spindle disappear and reappear on their own timeline, somewhat independently of the microtubules themselves.24PubMed Central. Impact of vitrification on the meiotic spindle and components of the microtubule-organizing center in mouse mature oocytes Temperature matters during the process: performing the vitrification steps at body temperature rather than room temperature dramatically shortened spindle recovery time in human oocytes, from roughly two and a half hours down to about eight minutes.25Fertility and Sterility. Influence of temperature on the meiotic spindle behavior of human oocytes during vitrification

Growing Oocytes from Stem Cells

Perhaps the most frontier area of oocyte research is in vitro gametogenesis, the effort to create functional egg cells from stem cells in a lab dish. In mice, this has already been achieved. Researchers have taken both embryonic stem cells and induced pluripotent stem cells (reprogrammed adult cells), coaxed them into becoming primordial germ cell-like cells, combined them with fetal ovarian tissue, and transplanted them into living mice. About a month later, those cells developed into full-size oocytes that could be fertilized in the lab and produce healthy, fertile offspring.26Nature Protocols. Generation of eggs from mouse embryonic stem cells and induced pluripotent stem cells

In humans, the technology is much earlier. Stem cells have been pushed to develop into early-stage oocytes but not into fully mature, fertilizable eggs.27PubMed. Mammalian in vitro gametogenesis The gap between mice and humans reflects the longer timeline and greater complexity of human oocyte development. Still, the work has generated considerable interest both for its potential to help people who have lost their ovarian reserve (due to cancer treatment, premature ovarian insufficiency, or age) and for the deep biological understanding it provides about how germ cells form in the first place. Ethical questions around this technology are substantial, since it could theoretically allow egg production on an industrial scale or the creation of gametes from people who never consented, but the practical reality is that the science is still years away from clinical use in humans.

Ethical Questions Around Oocyte Donation

Even without the science-fiction possibilities of stem-cell-derived eggs, oocytes already sit at the center of ongoing ethical debates. Egg donation involves a woman undergoing hormonal stimulation and an invasive retrieval procedure to provide oocytes to someone else, whether for fertility treatment, research, or egg-sharing arrangements. Key concerns include whether donors truly give informed consent given the complexity of the procedure and its risks, and the tension between compensating donors fairly for a demanding process and commodifying human reproductive material.25Fertility and Sterility. Influence of temperature on the meiotic spindle behavior of human oocytes during vitrification Different countries have taken wildly different regulatory approaches, ranging from outright bans on donor compensation to largely unregulated commercial markets, and the landscape continues to evolve as egg freezing becomes more mainstream and demand for donor eggs grows.